Bipolar pharmacotherapy and suicidal behavior. Part 2. The impact of antidepressants

Journal of Affective Disorders

Volumn 103, Issue 1-3, 2007, Pages 13-21

  Yerevanian, Boghos I ^a   Koek, Ralph J ^a,b   Mintz, Jim ^a   Akiskal, Hagop S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressants; Bipolar disorder; Longitudinal study; Public health; Suicide; Suicide attempt; Veterans

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR DISORDER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDAL BEHAVIOR; VETERAN;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SUICIDE; SUICIDE, ATTEMPTED; VETERANS;

EID: 34548822677     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.05.017     Document Type: Article

References (37)

1. Agresti A. Categorical Data Analysis (1990), John Wiley and Sons, New York, NY 189-196
2. Aizenberg D., Olmer A., and Barak Y. Suicide attempts amongst elderly bipolar patients. J. Affect. Disord. 91 (2006) 91-94
3. Akiskal H.S., and Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol. Bull. 23 (1987) 68-73
4. Akiskal H.S. Developmental pathways to bipolarity: are juvenile-onset depressions pre-bipolar?. J. Am. Acad. Child Adolesc. Psych. 34 (1995) 754-763
5. Akiskal H.S. What is the optimum strategy for the clinical management of bipolar depression?. J. Bipolar Disord. V 18 (2006)
6. Akiskal H.S., and Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J. Affect. Disord. 73 (2003) 113-122
7. Akiskal H.S., and Benazzi F. Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?. Psychopathology 38 (2005) 273-280
8. Akiskal H.S., Benazzi F., Perugi G., and Rihmer Z. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J. Affect. Disord. 85 (2005) 245-258
9. Baldessarini R.J., Pompili M., and Tondo L. Suicidal risk in antidepressant drug trials. Arch. Gen. Psychiatry 63 (2006) 246-248
10. Baldessarini R.J., Leahy L., Arcona S., Gause D., Zhang W., and Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr. Serv. 58 (2007) 85-91
11. Balazs J., Benazzi F., Rihmer Z., Rihmer A., Akiskal K.K., and Akiskal H.S. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord. 91 (2006) 133-138
12. Bauer M.S., Wisniewski S.R., Marangell L.B., Chessick C.A., Allen M.H., Dennehy E.B., Miklowitz D.J., Thase M.E., and Sachs G.S. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J. Clin. Psychiatry 67 (2006) 48-55
13. Berk M., and Dodd S. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?. Med. Hypotheses 65 (2005) 39-43
14. Dilsaver S.C., and Akiskal H.S. High rate of unrecognized bipolar mixed states among destitute Hispanic adolescents referred for "major depressive disorder". J. Affect. Disord. 84 (2005) 179-186
15. Fergusson D., Doucette S., Glass K.C., Shapiro S., Healy D., Hebert P., and Hutton B. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330 7488 (2005) 396
16. Food and Drug Administration (9-14-04), www.FDA.gov/bbs/topics/news/2004/new01116.html.
17. Ghaemi S.N., Hsu D.J., Soldani F., and Goodwin F.K. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 5 (2003) 421-433
18. Goldberg J.F., Allen M.H., Miklowitz D.A., Bowden C.L., Endick C.J., Chessick C.A., Wisniewski S.R., Miyahara S., Sagduyu K., Thase M.E., Calabrese J.R., and Sachs G.S. Suicidal ideation and pharmacotherapy among STEP-BD patients. Psychiatr. Serv. 56 (2005) 1534-1540
19. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Maser J., Solomon D.A., Leon A.C., Rice J.A., and Keller M.B. The long-term natural history of the weekly symptomatic status of bipolar-I disorder. Arch. Gen. Psychiatry 59 (2002) 530-537
20. Judd L.L., Akiskal H.S., Schettler P., Endicott J., Maser J., Solomon D., Leon A., Coryell W., and Keller M. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psychiatry 60 (2003) 261-269
21. Khan A., Khan S., Kolts R., and Brown W.A. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am. J. Psychiatry 160 (2003) 790-792
22. Koukopoulos A., Faedda G., Proietti R., D'Amico S., de Pisa E., and Simonetto C. Mixed depressive syndromes. Encéphale 18 Spec No 1 (1992) 19-21
23. Koukopoulos A., Sani G., Koukopoulos A.E., Manfredi G., Pacchiarotti I., and Girardi P. Melancholia agitata and mixed depression. Acta. Psychiatr. Scand. Suppl. 433 (2007) 50-57
24. Marangell L.B., Bauer M.S., Dennehy E.B., Wisniewsky S.R., Allen M.H., Miklowitz D.J., Oquendo M.A., Frank E., Perlis R.H., Martinez J.M., Fagiolini A., Otto M.W., Chessick C.A., Zboyan H.A., Miyahara S., Sachs G., and Thase M.E. Prospective predictors of suicide and suicide attempts in 1556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord. 8 (2006) 566-575
25. Maser J.D., Akiskal H.S., Zeller P., Scheftner W., Mueller T., Endicott J., Solomon D., and Clayton P. Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behavior? A 14-year prospective study. Suicide. Life-Threat. Behav. 32 (2002) 10-32
26. McElroy S.L., Kotwal R., Kaneria R., and Keck Jr. P.E. Antidepressants and suicidal behavior in bipolar disorder. Bipolar Disord. 8 (2006) 596-617
27. Moller H.-J. Evidence for beneficial effects of antidepressants on suicidality in depressive patients. A systematic review. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 229-343
28. Moller H.-J., Grunze H., and Broich K. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 1-16
29. Pompili M., Tondo L., and Baldessarini B. Suicidal risk emerging during antidepressant treatment: recognition and intervention. Clin. Neuropsychiatry 2 (2005) 66-72
30. Post R.M., Leverich G.S., Nolen W.A., Kupka R.W., Altshuler L.L., Frye M.A., Suppes T., McElroy S., Keck P., Grunze H., and Walden J. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 5 (2003) 396-406
31. Rihmer Z. Suicide risk in mood disorders. Curr. Opin. Psychiatry Jan. 20 1 (2002) 17-22
32. Rihmer Z., and Akiskal H.S. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J. Affect. Disord. 94 (2006) 3-13
33. Rihmer Z. Suicidal risk in mood disorders. Curr. Opin. Psychiatry 20 (2007) 17-22
34. Shi L., Thiebaud P., and McCombs J.S. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-service California Medicaid (Medi-Cal) programme. J. Affect. Disord. 82 (2004) 373-383
35. Simon N., Otto M., Weiss R., Bauer M.S., Miyahara S., Wisniewski S.R., Thase M.E., Kogan J., Frank E., Nierenberg A.A., Calabrese J.R., Sachs G.S., and Pollack M.H. Pharmacotherapy for bipolar disorder and co-morbid conditions: baseline data from STEP-BD. J. Clin. Psychopharmacol. 24 (2004) 512-520
36. Tondo L., and Baldessarini R.J. Reduced suicide risk during lithium maintenance treatment. J. Clin. Psychiatry, 61 suppl 9 (2000) 97-104
37. Valtonen H.M., Suominen K., Mantere O., Leppamaki S., Arvilommi P., and Isometsa E.T. Prospective study of risk factors for attempted suicide among patients with bipolar disorder. Bipolar Disord. 8 (2006) 576-585